These success, together with a preceding report displaying that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like conduct in mice,2 assist the idea of concentrating on ACKR3 as a singular solution to modulate the opioid program, which could open up new therapeutic avenues for opioid-similar Conditions. By ticking this box https://whatischronicpain65535.articlesblogger.com/56796933/conolidine-an-overview